## Abstract ## BACKGROUND The toxicity of platinumβbased combinations represents a common problem for patients with advanced urothelial carcinoma. The authors previously reported encouraging efficacy for the combination of carboplatin and gemcitabine in patients considered to be unfit for cisplati
β¦ LIBER β¦
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group
β Scribed by George Fountzilas; Dimitrios Pectasides; Anna Kalogera-Fountzila; Dimosthenis Skarlos; Haralambos P. Kalofonos; Christos Papadimitriou; Dimitrios Bafaloukos; Stefanos Lambropoulos; Savvas Papadopoulos; Helen Kourea; Christos Markopoulos; Helen Linardou; Dimitrios Mavroudis; Evangelos Briasoulis; Nicholaos Pavlidis; Evangelia Razis; Paraskevas Kosmidis; Helen Gogas
- Publisher
- Springer US
- Year
- 2005
- Tongue
- English
- Weight
- 218 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The combination of gemcitabine and carbo
β
Aristotle Bamias; Lia A. Moulopoulos; Aggelos Koutras; Gerassimos Aravantinos; G
π
Article
π
2006
π
John Wiley and Sons
π
English
β 132 KB
Combination docetaxel (Taxotere), fluoro
β
Pavlos Papakostas; Dimitrios Tsavdaridis; Paris Kosmidis; Haralabos P. Kalofonos
π
Article
π
2006
π
Springer
π
English
β 333 KB
Phase I/II study of a combination of doc
β
Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Su
π
Article
π
2010
π
Springer
π
English
β 334 KB